Practice Performance Assessment & Growth Blueprint
1. Executive Summary
This assessment outlines a clear, achievable path to transforming McCall Family Dentistry from a practice that works hard to one that works well. Over the course of this engagement, we will address four core themes: establishing financial clarity so every dollar is visible and intentional; reducing operational stress by replacing reactive problem-solving with reliable systems; building the infrastructure that supports sustainable, compounding growth; and increasing enterprise value so that whether you practice for five more years or twenty-five, every month adds tangible equity.
The pages that follow translate these themes into specific numbers, structures, and a phased execution plan. Nothing here requires heroic effort. Everything requires consistent, focused attention to the levers that actually move a dental practice forward.
Everything that follows is designed to intentionally improve performance, predictability, and optionality.
2. Why EBITDA Growth Matters
We organize every recommendation in this plan around a single financial concept: EBITDA—Earnings Before Interest, Taxes, Depreciation, and Amortization. EBITDA matters because it is the clearest measure of what your practice actually generates for you, and it is the number a buyer, lender, or partner will use to value the business.
Lifestyle & Cash Flow — A stronger EBITDA means more predictable income, less month-to-month stress, and the flexibility to make decisions from a position of strength rather than necessity.
Scale & Optionality — Margin funds growth. When your practice reliably generates surplus, you gain the ability to hire an associate, expand capacity, invest in marketing, or simply say "no" to things that don't serve you—all on your terms.
Transition Value — Whether a sale is five years away or fifteen, EBITDA is the multiplier base in virtually every dental practice valuation. Improving it by even a few points translates into hundreds of thousands of dollars in enterprise value.
Everything in this plan is designed to grow EBITDA not by working harder, but by improving systems, efficiency, and decision-making.
3. Snapshot: Current vs. Target Performance
The table below captures where the practice stands today against the performance profile we believe is achievable within a structured engagement. These are not aspirational ceilings—they reflect benchmarks consistently reached by well-managed practices of similar size and market position.
| Metric | Today | Target |
|---|---|---|
| Top-Line Revenue | ~$1.80M | ~$3.0M |
| Total Overhead | ~85% | 65–75% |
| EBITDA | ~10% (~$180K) | ~20% (~$600K) |
| Implied Practice Value (6.5×) | ~$1.17M | ~$3.9M |
Annual Cash Flow: EBITDA grows from ~$180K → ~$600K (+$420K/year)
Enterprise Value: Practice value grows from ~$1.17M → ~$3.9M (+$2.7M)
4. What This Means for the Three Paths Every Owner Is On
Every practice owner is simultaneously navigating three overlapping journeys. The financial improvements described above impact each one directly.
Lifestyle & Income
An additional $420K in annual cash flow changes the day-to-day experience of ownership. It means more take-home pay, the ability to fund retirement aggressively, and—critically—less chaos. When the practice generates healthy margin, you stop managing crises and start making choices. Staffing decisions come from strategy, not desperation. Time off becomes possible without financial anxiety.
Scaling & Growth
Margin is what funds intelligent growth. With a healthy EBITDA, the practice has the capacity to develop a productive associate, expand the hygiene department strategically, and invest in marketing that actually performs. Scaling from a position of profitability is fundamentally different from scaling to try to find profitability.
Transition & Exit
EBITDA is directly multiplied in a practice sale. The difference between a 10% margin and a 20% margin on $3M in revenue is not incremental—it is transformational. Higher EBITDA also attracts stronger buyers, better deal structures, and more favorable multiples. Even if a transition is years away, every improvement made today compounds into equity.
5. Doctor-Stated Goals
During our discovery process, Dr. McCall identified the following priorities. We list them here because this growth strategy was built to address each one directly:
- Clarify long-term vision for the practice and personal career
- Refine operational systems across the practice
- Establish clear roles and accountability for every team member
- Balance patient flow between providers and across the schedule
- Improve hygiene department production and profitability
- Develop the associate doctor into a consistent, high-performing producer
- Improve scheduling efficiency and reduce dead time
- Position the practice for maximum profitability and transition value
This growth strategy directly supports each of these goals.
6. Team Feedback: What the Organization Is Telling Us
Confidential team surveys revealed patterns that are both common and correctable. The issues surfaced are not about effort or attitude—they point to gaps in systems, structure, and communication that create friction and burnout.
Top Concerns
- Scheduling inefficiencies and frequent disruptions
- Team dynamics and interpersonal tension
- Low patient volume on certain days
- Stress and burnout among clinical staff
- Communication breakdowns between departments
Secondary Concerns
- Clinical organization and operatory readiness
- Lack of clarity around expectations and responsibilities
- Appointment flow and handoff inconsistencies
- Business office processes and patient follow-up
- Time management throughout the day
Key Insight: These concerns are less about effort and more about systems, structure, and clarity—all of which are addressable.
7. Primary Drivers of Practice Performance
Every dental practice, regardless of size or specialty mix, is governed by a small number of performance drivers. Improvement does not require addressing dozens of variables simultaneously—it requires focused, sequential attention to the handful of levers that account for the vast majority of outcomes.
-
Doctor Production & Scheduling
- Daily production targets aligned with revenue goals
- Schedule design that protects high-value time blocks
- Associate development and production accountability
-
Hygiene Optimization & Expansion
- Perio diagnosis rates and treatment compliance
- Fluoride and adjunctive service adoption
- Hygiene-to-doctor handoff and restorative diagnosis flow
-
Overhead Discipline
- Team cost as a percentage of collections
- Supply cost management and vendor negotiation
- Marketing ROI accountability
-
Patient Flow & A/R Control
- Recall effectiveness and reactivation systems
- Accounts receivable aging and collection protocols
- Case presentation and financial arrangement processes
-
New Patient & Case Acceptance Strategy
- New patient volume and cost-per-acquisition
- Conversion rates from exam to treatment
- Comprehensive case acceptance and follow-through
8. Production & Collection Opportunity
Based on current provider capacity, schedule structure, and market dynamics, we believe the practice can reasonably target $3.0–$3.4M in annual collections. This is not a ceiling—it is a mid-term benchmark that reflects what the existing infrastructure can support with improved systems and execution.
The major upside is tied to three specific areas: developing Dr. Egbaria into a consistent $4,000–$5,000/day producer, restructuring the schedule to eliminate dead time and protect high-value production blocks, and expanding hygiene capacity to both generate direct revenue and feed the restorative pipeline.
Collections today sit at approximately $1.80M. The gap between current and target performance is not a function of clinical skill or market demand—it is an operational gap, and operational gaps are the most reliably closable.
Key Insight: Growing into these goals with your current infrastructure would increase collections by nearly $1M annually.
9. Hygiene as a Growth Engine
The hygiene department is the most underleveraged growth asset in the practice. It is both a direct revenue center and the primary diagnostic engine for restorative and periodontal treatment. Optimizing hygiene is not about working faster—it is about diagnosing more completely and converting more effectively.
| Metric | Current | Target |
|---|---|---|
| Periodontal Diagnosis Rate | 5–6% | 20% |
| Fluoride Acceptance | 25–30% | 70% |
| Doctor Production Diagnosed in Hygiene | — | 60% |
Closing these gaps does not require adding columns to the schedule. It requires consistent protocols, calibrated diagnosis, and a team culture that treats hygiene as a clinical department—not a cleaning service.
10. Marketing & Patient Growth
New patient volume is the lifeblood of long-term practice health. Today the practice averages approximately 20 new patients per month. The target is 40 new patients per month—achievable with focused digital marketing, referral systems, and improved conversion at the front desk.
| Metric | Today | Target |
|---|---|---|
| New Patients / Month | ~20 | ~40 |
| Annual Production Impact | — | +$288K |
| Annual Collection Impact | — | +$240K |
Doubling new patient flow is significant, but it is a function of disciplined marketing spend, tracking ROI by channel, and ensuring the front office converts inquiries into scheduled appointments. The production and collection gains above assume conservative per-patient values and do not account for downstream restorative referrals.
11. Financial Discipline & Profitability
Overhead management is not about cutting—it is about aligning spend with production. The practice currently operates at approximately 85% total overhead, which leaves very little margin for the unexpected and compresses owner compensation. The target range of 65–75% is standard for a healthy, well-managed practice.
Immediate Savings Opportunities
| Area | Estimated Annual Savings |
|---|---|
| Supplies & Lab | $18K–$36K |
| Team Cost Optimization | ~$107K |
| Marketing Efficiency | ~$70K |
| Total | ~$200K |
These are not reductions in quality or capability. They represent spend that is currently producing little or no measurable return, and can be reallocated or eliminated without impacting patient experience or clinical outcomes.
12. Phased Execution Roadmap
Meaningful practice transformation does not happen all at once. It follows a deliberate sequence: Control → Efficiency → Growth. Each phase earns the right to the next. Skipping ahead—scaling before systems are in place, for instance—creates fragile growth that collapses under pressure.
What to Expect
Change management in a dental practice is real. There will be weeks where the new systems feel slower than the old habits. Team members will need time to internalize new expectations. During the active growth phase, plan for 2–4 hours per week of focused implementation work (meetings, reviews, system design). Once systems are running, maintenance drops to 1–2 hours per month. The return on that time investment is measured in hundreds of thousands of dollars.
Phase 1: Create Control
EBITDA Impact: Stop Margin Leakage
Key Actions:
- Establish daily/weekly KPI tracking and financial visibility
- Audit and renegotiate supply and lab contracts
- Implement scheduling templates with protected production blocks
- Define clear roles, responsibilities, and accountability metrics for every position
- Clean up A/R aging and tighten collection protocols
Direct EBITDA Impact:
- Recover $18K–$36K in supply savings
- Reduce team cost inefficiency (~$107K)
- Improve collection rate on existing production
Expected Result: Overhead drops from ~85% to ~78%, EBITDA improves to ~15% within 90–120 days. The practice feels calmer, more predictable, and financially legible.
Phase 2: Improve Efficiency
EBITDA Impact: Increase Profit per Hour
Key Actions:
- Optimize hygiene protocols—perio diagnosis, fluoride acceptance, co-diagnosis flow
- Develop associate production through mentorship, scheduling, and case coaching
- Implement case acceptance training and financial presentation systems
- Build marketing tracking and ROI accountability
Direct EBITDA Impact:
- Hygiene revenue increase from perio and adjunctive services
- Associate production grows toward $4,000–$5,000/day
- Marketing spend reallocated to highest-performing channels
Expected Result: Collections grow toward $2.2–$2.5M, overhead stabilizes at 70–75%, and EBITDA approaches 18–20%. The team operates with greater autonomy and less dependence on the doctor for every decision.
Phase 3: Scale Intentionally
EBITDA Impact: Multiply What Works
Key Actions:
- Expand hygiene department capacity (additional columns or hours)
- Scale new patient acquisition to 40+/month
- Formalize associate pathway—compensation, autonomy, potential partnership
- Build transition-ready documentation and practice valuation file
Direct EBITDA Impact:
- Revenue scales toward $3.0–$3.4M
- Fixed overhead is spread across higher production base
- Enterprise value compounds with every quarter of improved performance
Expected Result: Collections reach $3.0M+, EBITDA sustains at 20%+, and the practice is positioned for a premium valuation. The owner has genuine optionality—continue, partner, or exit on favorable terms.
Phase Summary
| Phase | EBITDA Effect |
|---|---|
| Phase 1: Create Control | Stop margin leakage → recover ~$150K+ in annual waste |
| Phase 2: Improve Efficiency | Increase profit per hour → grow collections to $2.2–$2.5M |
| Phase 3: Scale Intentionally | Multiply what works → $3.0M+ collections, 20%+ EBITDA |
Stop margin leakage
18–20% EBITDA
20%+ EBITDA
By Phase 3: Annual EBITDA of ~$600K, implied practice value of ~$3.9M, and an owner who has the freedom to choose what comes next—not because the practice demands it, but because the numbers support it.
13. Bottom Line
This is not a motivational plan. This is a mechanical EBITDA improvement system.
Each phase earns the right to the next. The financial gains generated in Phase 1 fund the investments made in Phase 2. The efficiency built in Phase 2 creates the capacity leveraged in Phase 3. At no point does the plan require the doctor to produce more hours or absorb more stress. The entire design moves in the opposite direction: more margin, more support, more freedom.
The doctor should feel relief, not pressure. The team should feel clarity, not chaos. And the numbers should feel inevitable, not aspirational—because they are built on systems, not heroics.
14. Reference Data
The following data informed the analysis and recommendations above. It is included here for reference and ongoing tracking.
Top Adjustments
- Insurance write-offs and fee schedule alignment
- Production adjustments from cancelled/rescheduled treatment
- Lab case remakes and warranty work
- Courtesy discounts and professional adjustments
Provider Production Data
| Provider | Daily Average | Perio % | Fluoride % |
|---|---|---|---|
| Dr. McCall (Lead) | $3,800 | — | — |
| Dr. Egbaria (Associate) | $2,100 | — | — |
| Hygienist 1 | $1,200 | 5% | 28% |
| Hygienist 2 | $1,050 | 6% | 25% |
Suggested Daily Goals
| Provider | Target Daily Production |
|---|---|
| Dr. McCall | $5,500–$6,500 |
| Dr. Egbaria | $4,000–$5,000 |
| Hygienist (each) | $1,600–$1,800 |
Accounts Receivable Breakdown
| Aging Bucket | Amount |
|---|---|
| 0–30 days | $85K |
| 31–60 days | $42K |
| 61–90 days | $28K |
| 90+ days | $35K |
| Total A/R | $190K |
New Patient Data
| Metric | Current |
|---|---|
| Average New Patients / Month | ~20 |
| Primary Source | Referrals, Google |
| Cost per Acquisition | Untracked |
Treatment Acceptance
| Metric | Current | Target |
|---|---|---|
| Case Acceptance Rate | ~55% | 75–85% |
| Unscheduled Treatment | $380K+ | <$150K |
Hygiene Department Hours & Findings
| Metric | Current | Notes |
|---|---|---|
| Hygiene Columns | 2 | Operating 4 days/week each |
| Total Hygiene Hours / Week | ~64 | Opportunity to expand to 5 days |
| Perio Diagnosis Rate | 5–6% | National benchmark: 20%+ |
| Fluoride Acceptance | 25–30% | Top practices: 70%+ |
| Hygiene-Sourced Doctor Production | Not tracked | Target: 60% of restorative |
Prepared by XPO Dental Partners · Confidential · April 2026
